Targeting oxidative stress with amobarbital to prevent intervertebral disc degeneration: part II. Rabbit disc...

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedics

Background:

• Oxidative stress contributes to post-traumatic intervertebral disc degeneration.
• Targeting oxidant metabolism in disc cells is a potential therapeutic strategy.
• Amobarbital suppresses mitochondrial activity and shows promise for mitigating disc degeneration.

Purpose of the Study:

• To investigate the preventive effects of amobarbital on disc degeneration progression.
• To evaluate amobarbital's efficacy in a rabbit disc herniation model.

Main Methods:

• Amobarbital was delivered via a Pluronic F-127/hyaluronic acid hydrogel into the nucleus pulposus (NP) of herniated discs.
• Effects were evaluated in ex vivo and in vivo rabbit models using histological analysis, immunohistochemistry, and radiography.
• Spine segments and animals were randomized into intact, vehicle control, and amobarbital groups.

Main Results:

• Amobarbital demonstrated uniform distribution and sustained release (3-4 days) within the NP.
• In organ culture, amobarbital prevented morphologic changes, extracellular matrix damage, chondrocyte migration, and apoptosis.
• In vivo studies confirmed amobarbital's preventive effects, maintaining disc height at 2 weeks.

Conclusions:

• Amobarbital, encapsulated in hydrogel, effectively reduces degenerative changes in herniated discs.
• This drug delivery system shows potential for clinical application in treating intervertebral disc degeneration.
• Amobarbital delivered to NP cells may serve as a therapeutic option to retard disc degeneration.